Sleep & Depression
topic
Sleep and depression share a mechanistically understood bidirectional relationship — with insomnia being the most common symptom of depression (present in 75% of cases), an independent risk factor for future depressive episodes (2x elevated risk in longitudinal studies), and a predictor of treatment resistance and relapse. REM sleep alterations are among the most consistent neurobiological markers of depression (REM onset earlier than normal, first REM period longer, total REM increased), while REM sleep's emotional decontextualization function provides the mechanistic explanation for sleep's role in emotional recovery.
Role
The insomnia-depression bidirectionality means that treating depression without treating the accompanying insomnia substantially increases relapse risk — yet most antidepressant treatments either ignore sleep or actively alter it in ways that may be counterproductive (most antidepressants suppress REM). The research finding that CBT-I treatment of insomnia in people with comorbid depression improves depressive outcomes significantly — in some studies as much as depression-specific treatment — makes sleep the most accessible, least recognized leverage point in depression management available to both clinicians and individuals.